Purpose

The goal of this infrastructure grant is to establish and maintain a cohort of over 12,000 non-Hodgkin lymphoma (NHL) patients to support broad and cutting-edge research that identifies clinical (including co-morbid diseases), epidemiologic (including lifestyle and other exposures), host genetic, tumor, and treatment factors, as well as the interaction among these factors, on short and long-term outcomes. These efforts will identify new approaches to improve the survival and well-being of NHL patients.

Category

IRB Number
20190091HU
NCT Number
NCT02736357
Sponsor
Mayo Clinic -



Study Contact

Principal Investigator
Adolfo Diaz Duque

Frances Crawford
210-450-5037
crawfordf1@uthscsa.edu

Myrna Montenegro
210-450-5954
montenegro@uthscsa.edu

Kathleen Rodriguez
210-450-1365
rodriguezk3@uthscsa.edu

Benjamin Schleif
210-450-1366
schleifb@uthscsa.edu

Morgan Seekatz
210-450-1133
seekatz@uthscsa.edu



Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

    • Newly diagnosed non-Hodgkin Lymphoma (NHL), within 183 days of enrollment
    • Patients may have been treated as long as initial NHL diagnosis is within 6 months of enrollment
    • 18 years of age or older

Exclusion Criteria

    • Lymphoma diagnosis greater than 184 days from date of consent

Study Design

Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Prospective
Condition
  • Non-Hodgkin Lymphoma

    • Arm Groups